{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:42:42Z","timestamp":1785526962698,"version":"3.56.0"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During aging, the progressive decline in neuronal function contributes to cognitive impairment and predisposes individuals to neurodegenerative disorders. This phenomenon has become increasingly prominent in modern society. Recent studies have found that post-translational modifications (PTMs) of proteins play a crucial role in the aging process, influencing the physiological functions and pathological changes in brain cells. This article reviews the variety and complexity of PTMs across brain cell types during aging, analyzes changes in specific modification types and sites, and reveals their impacts on neurophysiological and pathological states. This review also examines the current state of translational research, noting that most of the drugs under investigation lack specificity, and their potential toxic side effects remain undetermined. In light of these concerns, this review proposes therapeutic strategies to guide innovative interventions for aging-related diseases, aiming to facilitate further research and clinical applications in this field.<\/jats:p>","DOI":"10.1038\/s41419-026-08917-5","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:16:49Z","timestamp":1780046209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone modification dynamics in brain aging: unlocking therapeutic potential"],"prefix":"10.1038","volume":"17","author":[{"given":"Bohao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikedan","family":"Yilixiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luojinyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-8854","authenticated-orcid":false,"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0488-4478","authenticated-orcid":false,"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"8917_CR1","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1007\/s11427-022-2161-3","volume":"65","author":"Y Cai","year":"2022","unstructured":"Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, et al. The landscape of aging. Sci China Life Sci. 2022;65:2354\u2013454.","journal-title":"Sci China Life Sci"},{"key":"8917_CR2","doi-asserted-by":"crossref","unstructured":"Nyberg L, W\u00e5hlin A. The many facets of brain aging. eLife. 2020;9:e56640.","DOI":"10.7554\/eLife.56640"},{"key":"8917_CR3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 2018;27:1176\u201399.","journal-title":"Cell Metab"},{"key":"8917_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102141","volume":"93","author":"LS Melo Dos Santos","year":"2024","unstructured":"Melo Dos Santos LS, Trombetta-Lima M, Eggen B, Demaria M. Cellular senescence in brain aging and neurodegeneration. Ageing Res Rev. 2024;93:102141.","journal-title":"Ageing Res Rev"},{"key":"8917_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.646924","volume":"13","author":"E Sikora","year":"2021","unstructured":"Sikora E, Bielak-Zmijewska A, Dudkowska M, Krzystyniak A, Mosieniak G, Wesierska M, et al. Cellular senescence in brain aging. Front Aging Neurosci. 2021;13:646924.","journal-title":"Front Aging Neurosci"},{"key":"8917_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105008","volume":"143","author":"IH Salas","year":"2020","unstructured":"Salas IH, Burgado J, Allen NJ. Glia: victims or villains of the aging brain? Neurobiol Dis. 2020;143:105008.","journal-title":"Neurobiol Dis"},{"key":"8917_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13311-019-00743-2","volume":"16","author":"G Lupo","year":"2019","unstructured":"Lupo G, Gaetani S, Cacci E, Biagioni S, Negri R. Molecular signatures of the aging brain: finding the links between genes and phenotypes. NeuroTherapeutics. 2019;16:543\u201353.","journal-title":"NeuroTherapeutics"},{"key":"8917_CR8","first-page":"1726","volume":"15","author":"L Soraci","year":"2024","unstructured":"Soraci L, Corsonello A, Paparazzo E, Montesanto A, Piacenza F, Olivieri F, et al. Neuroinflammaging: a tight line between normal aging and age-related neurodegenerative disorders. Aging Dis. 2024;15:1726\u201347.","journal-title":"Aging Dis"},{"key":"8917_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39809-8","volume":"9","author":"P Coup\u00e9","year":"2019","unstructured":"Coup\u00e9 P, Manj\u00f3n JV, Lanuza E, Catheline G. Lifespan changes of the human brain in Alzheimer\u2019s disease. Sci Rep. 2019;9:3998.","journal-title":"Sci Rep"},{"key":"8917_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrm.2017.68","volume":"18","author":"N Kubben","year":"2017","unstructured":"Kubben N, Misteli T. Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat Rev Mol Cell Biol. 2017;18:595\u2013609.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8917_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002611","volume":"7","author":"S Song","year":"2020","unstructured":"Song S, Tchkonia T, Jiang J, Kirkland JL, Sun Y. Targeting senescent cells for a healthier aging: challenges and opportunities. Adv Sci. 2020;7:2002611.","journal-title":"Adv Sci"},{"key":"8917_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41\u20135.","journal-title":"Nature"},{"key":"8917_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cell.2008.10.036","volume":"135","author":"T Suganuma","year":"2008","unstructured":"Suganuma T, Workman JL. Crosstalk among histone modifications. Cell. 2008;135:604\u20137.","journal-title":"Cell"},{"key":"8917_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2217\/nmt-2018-0004","volume":"8","author":"A Stoccoro","year":"2018","unstructured":"Stoccoro A, Copped\u00e8 F. Role of epigenetics in Alzheimer\u2019s disease pathogenesis. Neurodegener Dis Manag. 2018;8:181\u201393.","journal-title":"Neurodegener Dis Manag"},{"key":"8917_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tips.2023.12.002","volume":"45","author":"Z Wu","year":"2024","unstructured":"Wu Z, Zhang W, Qu J, Liu GH. Emerging epigenetic insights into aging mechanisms and interventions. Trends Pharmacol Sci. 2024;45:157\u201372.","journal-title":"Trends Pharmacol Sci"},{"key":"8917_CR16","doi-asserted-by":"publisher","first-page":"15882","DOI":"10.18632\/oncotarget.4137","volume":"6","author":"H Gong","year":"2015","unstructured":"Gong H, Qian H, Ertl R, Astle CM, Wang GG, Harrison DE, et al. Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget. 2015;6:15882\u201390.","journal-title":"Oncotarget"},{"key":"8917_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fgene.2017.00138","volume":"8","author":"C Sidler","year":"2017","unstructured":"Sidler C, Kovalchuk O, Kovalchuk I. Epigenetic regulation of cellular senescence and aging. Front Genet. 2017;8:138.","journal-title":"Front Genet"},{"key":"8917_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-53889-1_15","volume":"978","author":"S Bassi","year":"2017","unstructured":"Bassi S, Tripathi T, Monziani A, Di Leva F, Biagioli M. Epigenetics of Huntington\u2019s disease. Adv Exp Med Biol. 2017;978:277\u201399.","journal-title":"Adv Exp Med Biol"},{"key":"8917_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nrn2499","volume":"9","author":"HC Tai","year":"2008","unstructured":"Tai HC, Schuman EM. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci. 2008;9:826\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"8917_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt MF, Gan ZY, Komander D, Dewson G. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ. 2021;28:570\u201390.","journal-title":"Cell Death Differ"},{"key":"8917_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ceb.2008.01.012","volume":"20","author":"L Song","year":"2008","unstructured":"Song L, Rape M. Reverse the curse-the role of deubiquitination in cell cycle control. Curr Opin Cell Biol. 2008;20:156\u201363.","journal-title":"Curr Opin Cell Biol"},{"key":"8917_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41586-021-03781-z","volume":"596","author":"S Koyuncu","year":"2021","unstructured":"Koyuncu S, Loureiro R, Lee HJ, Wagle P, Krueger M, Vilchez D. Rewiring of the ubiquitinated proteome determines ageing in C. elegans. Nature. 2021;596:285\u201390.","journal-title":"Nature"},{"key":"8917_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10136-w","volume":"10","author":"L Yang","year":"2019","unstructured":"Yang L, Ma Z, Wang H, Niu K, Cao Y, Sun L, et al. Ubiquitylome study identifies increased histone 2A ubiquitylation as an evolutionarily conserved aging biomarker. Nat Commun. 2019;10:2191.","journal-title":"Nat Commun"},{"key":"8917_CR24","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209596","volume":"16","author":"E Kelmer Sacramento","year":"2020","unstructured":"Kelmer Sacramento E, Kirkpatrick JM, Mazzetto M, Baumgart M, Bartolome A, Di Sanzo S, et al. Reduced proteasome activity in the aging brain results in ribosome stoichiometry loss and aggregation. Mol Syst Biol. 2020;16:e9596.","journal-title":"Mol Syst Biol"},{"key":"8917_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70048","volume":"21","author":"L Wang","year":"2025","unstructured":"Wang L, Sooram B, Kumar R, Schedin-Weiss S, Tjernberg LO, Winblad B. Tau degradation in Alzheimer\u2019s disease: mechanisms and therapeutic opportunities. Alzheimer\u2019s Dement. 2025;21. e70048.","journal-title":"Alzheimer\u2019s Dement"},{"key":"8917_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.4161\/epi.21975","volume":"7","author":"D Rossetto","year":"2012","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics. 2012;7:1098\u2013108.","journal-title":"Epigenetics"},{"key":"8917_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ncb1095","volume":"6","author":"OA Sedelnikova","year":"2004","unstructured":"Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol. 2004;6:168\u201370.","journal-title":"Nat Cell Biol"},{"key":"8917_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnagi.2019.00114","volume":"11","author":"ZX Wu","year":"2019","unstructured":"Wu ZX, Cao L, Li XW, Jiang W, Li XY, Xu J, et al. Accelerated deficits of spatial learning and memory resulting from prenatal inflammatory insult are correlated with abnormal phosphorylation and methylation of histone 3 in CD-1 Mice. Front Aging Neurosci. 2019;11:114.","journal-title":"Front Aging Neurosci"},{"key":"8917_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"8917_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","volume":"38","author":"X Dai","year":"2022","unstructured":"Dai X, Lv X, Thompson EW, Ostrikov KK. Histone lactylation: epigenetic mark of glycolytic switch. Trends Genet. 2022;38:124\u20137.","journal-title":"Trends Genet"},{"key":"8917_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8:eabi6696.","journal-title":"Sci Adv"},{"key":"8917_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03303-4","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li P, Xu Y, Feng L, Fang Y, Song G, et al. Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms. J Neuroinflamm. 2024;21:308.","journal-title":"J Neuroinflamm"},{"key":"8917_CR33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan RY, He L, Zhang J, Liu X, Liao Y, Gao J, et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 2022;34:634\u2013648.e636.","journal-title":"Cell Metab"},{"key":"8917_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood-brain barrier. Nat aging. 2021;1:243\u201354.","journal-title":"Nat aging"},{"key":"8917_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-019-0204-5","volume":"21","author":"W Zhang","year":"2020","unstructured":"Zhang W, Qu J, Liu GH, Belmonte JCI. The ageing epigenome and its rejuvenation. Nat Rev Mol Cell Biol. 2020;21:137\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8917_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnmol.2020.00041","volume":"13","author":"A Kandlur","year":"2020","unstructured":"Kandlur A, Satyamoorthy K, Gangadharan G. Oxidative stress in cognitive and epigenetic aging: a retrospective glance. Front Mol Neurosci. 2020;13:41.","journal-title":"Front Mol Neurosci"},{"key":"8917_CR37","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bbadis.2017.11.004","volume":"1864","author":"M Neal","year":"2018","unstructured":"Neal M, Richardson JR. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration. Biochim et Biophys Acta Mol Basis Dis. 2018;1864:432\u201343.","journal-title":"Biochim et Biophys Acta Mol Basis Dis"},{"key":"8917_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13817","volume":"22","author":"V Budamagunta","year":"2023","unstructured":"Budamagunta V, Kumar A, Rani A, Bean L, Manohar-Sindhu S, Yang Y, et al. Effect of peripheral cellular senescence on brain aging and cognitive decline. Aging cell. 2023;22:e13817.","journal-title":"Aging cell"},{"key":"8917_CR39","doi-asserted-by":"crossref","unstructured":"Song S, Johnson FB. Epigenetic mechanisms impacting aging: a focus on histone levels and telomeres. Genes 2018;9:201.","DOI":"10.3390\/genes9040201"},{"key":"8917_CR40","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cell.2018.03.079","volume":"173","author":"P Cheung","year":"2018","unstructured":"Cheung P, Vallania F, Warsinske HC, Donato M, Schaffert S, Chang SE, et al. Single-cell chromatin modification profiling reveals increased epigenetic variations with aging. Cell. 2018;173:1385\u201397.e1314.","journal-title":"Cell"},{"key":"8917_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14031","volume":"8","author":"S Kishimoto","year":"2017","unstructured":"Kishimoto S, Uno M, Okabe E, Nono M, Nishida E. Environmental stresses induce transgenerationally inheritable survival advantages via germline-to-soma communication in Caenorhabditis elegans. Nat Commun. 2017;8:14031.","journal-title":"Nat Commun"},{"key":"8917_CR42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/1073858418780971","volume":"24","author":"JD Barter","year":"2018","unstructured":"Barter JD, Foster TC. Aging in the brain: new roles of epigenetics in cognitive decline. Neuroscientist. 2018;24:516\u201325.","journal-title":"Neuroscientist"},{"key":"8917_CR43","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.1800656115","volume":"115","author":"H Cheng","year":"2018","unstructured":"Cheng H, Xuan H, Green CD, Han Y, Sun N, Shen H, et al. Repression of human and mouse brain inflammaging transcriptome by broad gene-body histone hyperacetylation. Proc Natl Acad Sci USA. 2018;115:7611\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR44","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1007\/s12035-017-0490-x","volume":"55","author":"P Singh","year":"2018","unstructured":"Singh P, Thakur MK. Histone Deacetylase 2 inhibition attenuates downregulation of hippocampal plasticity gene expression during aging. Mol Neurobiol. 2018;55:2432\u201342.","journal-title":"Mol Neurobiol"},{"key":"8917_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10522-017-9685-9","volume":"18","author":"W Grabowska","year":"2017","unstructured":"Grabowska W, Sikora E, Bielak-Zmijewska A. Sirtuins, a promising target in slowing down the ageing process. Biogerontology. 2017;18:447\u201376.","journal-title":"Biogerontology"},{"key":"8917_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","volume":"23","author":"EF Fang","year":"2017","unstructured":"Fang EF, Lautrup S, Hou Y, Demarest TG, Croteau DL, Mattson MP, et al. NAD(+) in aging: molecular mechanisms and translational implications. Trends Mol Med. 2017;23:899\u2013916.","journal-title":"Trends Mol Med"},{"key":"8917_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fncel.2015.00167","volume":"9","author":"N Braidy","year":"2015","unstructured":"Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T, et al. Differential expression of sirtuins in the aging rat brain. Front Cell Neurosci. 2015;9:167.","journal-title":"Front Cell Neurosci"},{"key":"8917_CR48","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nature09271","volume":"466","author":"J Gao","year":"2010","unstructured":"Gao J, Wang WY, Mao YW, Gr\u00e4ff J, Guan JS, Pan L, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466:1105\u20139.","journal-title":"Nature"},{"key":"8917_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fncel.2015.00064","volume":"9","author":"F Ng","year":"2015","unstructured":"Ng F, Wijaya L, Tang BL. SIRT1 in the brain-connections with aging-associated disorders and lifespan. Front Cell Neurosci. 2015;9:64.","journal-title":"Front Cell Neurosci"},{"key":"8917_CR50","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.celrep.2016.08.028","volume":"16","author":"E Palomer","year":"2016","unstructured":"Palomer E, Mart\u00edn-Segura A, Baliyan S, Ahmed T, Balschun D, Venero C, et al. Aging triggers a repressive chromatin state at bdnf promoters in hippocampal neurons. Cell Rep. 2016;16:2889\u2013900.","journal-title":"Cell Rep"},{"key":"8917_CR51","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01080","volume":"419","author":"H Santos-Rosa","year":"2002","unstructured":"Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, et al. Active genes are tri-methylated at K4 of histone H3. Nature. 2002;419:407\u201311.","journal-title":"Nature"},{"key":"8917_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.nlm.2019.04.009","volume":"161","author":"BE Collins","year":"2019","unstructured":"Collins BE, Sweatt JD, Greer CB. Broad domains of histone 3 lysine 4 trimethylation are associated with transcriptional activation in CA1 neurons of the hippocampus during memory formation. Neurobiol Learn Mem. 2019;161:149\u201357.","journal-title":"Neurobiol Learn Mem"},{"key":"8917_CR53","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.1073\/pnas.1001702107","volume":"107","author":"I Cheung","year":"2010","unstructured":"Cheung I, Shulha HP, Jiang Y, Matevossian A, Wang J, Weng Z, et al. Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc Natl Acad Sci USA. 2010;107:8824\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fmed.2018.00061","volume":"5","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, et al. The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med. 2018;5:61.","journal-title":"Front Med"},{"key":"8917_CR55","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.18632\/aging.101617","volume":"10","author":"N Yang","year":"2018","unstructured":"Yang N, Sen P. The senescent cell epigenome. Aging. 2018;10:3590\u2013609.","journal-title":"Aging"},{"key":"8917_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10522-019-09850-1","volume":"21","author":"A Kushwaha","year":"2020","unstructured":"Kushwaha A, Thakur MK. Increase in hippocampal histone H3K9me3 is negatively correlated with memory in old male mice. Biogerontology. 2020;21:175\u201389.","journal-title":"Biogerontology"},{"key":"8917_CR57","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12035-023-03570-x","volume":"61","author":"A Kushwaha","year":"2024","unstructured":"Kushwaha A, Thakur MK. Suv39h1 silencing recovers memory decline in scopolamine-induced amnesic mouse model. Mol Neurobiol. 2024;61:487\u201397.","journal-title":"Mol Neurobiol"},{"key":"8917_CR58","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-020-2037-y","volume":"579","author":"J Yuan","year":"2020","unstructured":"Yuan J, Chang SY, Yin SG, Liu ZY, Cheng X, Liu XJ, et al. Two conserved epigenetic regulators prevent healthy ageing. Nature. 2020;579:118\u201322.","journal-title":"Nature"},{"key":"8917_CR59","first-page":"2130","volume":"16","author":"X Jiang","year":"2024","unstructured":"Jiang X, Yang Y, Li X, Li T, Yu T, Fu X. Lactylation: an innovative approach to disease control. Aging Dis. 2024;16:2130\u201350.","journal-title":"Aging Dis"},{"key":"8917_CR60","doi-asserted-by":"crossref","unstructured":"Wu Y, Hu H, Liu W, Zhao Y, Xie F, Sun Z, et al. Hippocampal lactate-infusion enhances spatial memory correlated with monocarboxylate transporter 2 and Lactylation. Brain Sci. 2024;14:327.","DOI":"10.3390\/brainsci14040327"},{"key":"8917_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24421","volume":"10","author":"Z Lei","year":"2024","unstructured":"Lei Z, Mozaffaritabar S, Kawamura T, Koike A, Kolonics A, K\u00e9ringer J, et al. The effects of long-term lactate and high-intensity interval training (HIIT) on brain neuroplasticity of aged mice. Heliyon. 2024;10:e24421.","journal-title":"Heliyon"},{"key":"8917_CR62","doi-asserted-by":"publisher","first-page":"20087","DOI":"10.1073\/pnas.1008189107","volume":"107","author":"JM Ross","year":"2010","unstructured":"Ross JM, \u00d6berg J, Bren\u00e9 S, Coppotelli G, Terzioglu M, Pernold K, et al. High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A\/B ratio. Proc Natl Acad Sci USA. 2010;107:20087\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR63","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1073\/pnas.1017750108","volume":"108","author":"B Quistorff","year":"2011","unstructured":"Quistorff B, Grunnet N. High brain lactate is not caused by a shift in the lactate dehydrogenase A\/B ratio. Proc Natl Acad Sci USA. 2011;108:E21.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111512","volume":"197","author":"J Costa","year":"2021","unstructured":"Costa J, Martins S, Ferreira PA, Cardoso AMS, Guedes JR, Pe\u00e7a J, et al. The old guard: Age-related changes in microglia and their consequences. Mech Ageing Dev. 2021;197:111512.","journal-title":"Mech Ageing Dev"},{"key":"8917_CR65","doi-asserted-by":"crossref","unstructured":"Auzmendi-Iriarte J, Moreno-Cugnon L, Saenz-Anto\u00f1anzas A, Grassi D, de Pancorbo MM, Arevalo MA, et al. High levels of HDAC expression correlate with microglial aging. Expert Opin Ther Targets. 2022;26:911\u201322.","DOI":"10.1080\/14728222.2022.2158081"},{"key":"8917_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-3-319-40764-7_10","volume":"949","author":"F Cornejo","year":"2016","unstructured":"Cornejo F, von Bernhardi R. Age-dependent changes in the activation and regulation of microglia. Adv Exp Med Biol. 2016;949:205\u201326.","journal-title":"Adv Exp Med Biol"},{"key":"8917_CR67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2013.159","volume":"21","author":"Y Tang","year":"2014","unstructured":"Tang Y, Li T, Li J, Yang J, Liu H, Zhang XJ, et al. Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson\u2019s disease. Cell Death Differ. 2014;21:369\u201380.","journal-title":"Cell Death Differ"},{"key":"8917_CR68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fnagi.2015.00124","volume":"7","author":"R von Bernhardi","year":"2015","unstructured":"von Bernhardi R, Eugen\u00edn-von Bernhardi L, Eugen\u00edn J. Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci. 2015;7:124.","journal-title":"Front Aging Neurosci"},{"key":"8917_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70232","volume":"24","author":"C Hartmann","year":"2025","unstructured":"Hartmann C, Ha\u00df C, Knobloch M, Barrantes I, Fumagalli L, Premereur J, et al. Prematurely aged human microglia exhibit impaired stress response and defective nucleocytoplasmic shuttling of ALS Associated FUS. Aging Cell. 2025;24:e70232.","journal-title":"Aging Cell"},{"key":"8917_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02295-1","volume":"11","author":"M \u0160kand\u00edk","year":"2025","unstructured":"\u0160kand\u00edk M, Friess L, V\u00e1zquez-Cabrera G, Keane L, Grabert K, Cruz De Los Santos M, et al. Age-associated microglial transcriptome leads to diminished immunogenicity and dysregulation of MCT4 and P2RY12\/P2RY13 related functions. Cell Death Discov. 2025;11:16.","journal-title":"Cell Death Discov"},{"key":"8917_CR71","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1084\/jem.20171417","volume":"215","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang Y, Yuan J, Li N, Pei S, Xu J, et al. Macrophage\/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3. J Exp Med. 2018;215:1365\u201382.","journal-title":"J Exp Med"},{"key":"8917_CR72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2009.07.019","volume":"36","author":"G Faraco","year":"2009","unstructured":"Faraco G, Pittelli M, Cavone L, Fossati S, Porcu M, Mascagni P, et al. Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis. 2009;36:269\u201379.","journal-title":"Neurobiol Dis"},{"key":"8917_CR73","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/glia.1061","volume":"34","author":"W Cui","year":"2001","unstructured":"Cui W, Allen ND, Skynner M, Gusterson B, Clark AJ. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia. 2001;34:272\u201382.","journal-title":"Glia"},{"key":"8917_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987.","journal-title":"Front Aging Neurosci"},{"key":"8917_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2013.07.007","volume":"263","author":"S Kalinin","year":"2013","unstructured":"Kalinin S, Polak PE, Lin SX, Braun D, Guizzetti M, Zhang X, et al. Dimethyl fumarate regulates histone deacetylase expression in astrocytes. J Neuroimmunol. 2013;263:13\u20139.","journal-title":"J Neuroimmunol"},{"key":"8917_CR76","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2011.06.016","volume":"44","author":"F Correa","year":"2011","unstructured":"Correa F, Mallard C, Nilsson M, Sandberg M. Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3\u03b2. Neurobiol Dis. 2011;44:142\u201351.","journal-title":"Neurobiol Dis"},{"key":"8917_CR77","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","volume":"60","author":"Z Marinova","year":"2011","unstructured":"Marinova Z, Leng Y, Leeds P, Chuang DM. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons. Neuropharmacology. 2011;60:1109\u201315.","journal-title":"Neuropharmacology"},{"key":"8917_CR78","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296\u2013302.","journal-title":"Neuron"},{"key":"8917_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102395","volume":"99","author":"S Cunha","year":"2024","unstructured":"Cunha S, Bicker J, Sereno J, Falc\u00e3o A, Fortuna A. Blood brain barrier dysfunction in healthy aging and dementia: why, how, what for? Ageing Res Rev. 2024;99:102395.","journal-title":"Ageing Res Rev"},{"key":"8917_CR80","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27:2659\u201373.","journal-title":"Mol Psychiatry"},{"key":"8917_CR81","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nbd.2018.09.006","volume":"126","author":"SM Stamatovic","year":"2019","unstructured":"Stamatovic SM, Martinez-Revollar G, Hu A, Choi J, Keep RF, Andjelkovic AV. Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging. Neurobiol Dis. 2019;126:105\u201316.","journal-title":"Neurobiol Dis"},{"key":"8917_CR82","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1016\/j.cell.2023.11.001","volume":"186","author":"Y Li","year":"2023","unstructured":"Li Y, Di C, Song S, Zhang Y, Lu Y, Liao J, et al. Choroid plexus mast cells drive tumor-associated hydrocephalus. Cell. 2023;186:5719\u201338.e5728.","journal-title":"Cell"},{"key":"8917_CR83","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature13163","volume":"507","author":"T Lu","year":"2014","unstructured":"Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, et al. REST and stress resistance in ageing and Alzheimer\u2019s disease. Nature. 2014;507:448\u201354.","journal-title":"Nature"},{"key":"8917_CR84","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2023;19:1598\u2013695.","DOI":"10.1002\/alz.13016"},{"key":"8917_CR85","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787\u201395.","journal-title":"Nature"},{"key":"8917_CR86","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/15592294.2021.1959742","volume":"17","author":"M Beaver","year":"2022","unstructured":"Beaver M, Karisetty BC, Zhang H, Bhatnagar A, Armour E, Parmar V, et al. Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT\/HDAC2 epigenomic landscape in the neurodegenerative brain. Epigenetics. 2022;17:786\u2013807.","journal-title":"Epigenetics"},{"key":"8917_CR87","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10522-014-9504-5","volume":"15","author":"P Singh","year":"2014","unstructured":"Singh P, Thakur MK. Reduced recognition memory is correlated with decrease in DNA methyltransferase1 and increase in histone deacetylase2 protein expression in old male mice. Biogerontology. 2014;15:339\u201346.","journal-title":"Biogerontology"},{"key":"8917_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00625-4","volume":"18","author":"Y Lin","year":"2023","unstructured":"Lin Y, Lin A, Cai L, Huang W, Yan S, Wei Y, et al. ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2023;18:47.","journal-title":"Mol Neurodegener"},{"key":"8917_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13456","volume":"20","author":"W Wang","year":"2021","unstructured":"Wang W, Cao Q, Tan T, Yang F, Williams JB, Yan Z. Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model. Aging Cell. 2021;20:e13456.","journal-title":"Aging Cell"},{"key":"8917_CR90","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/brain\/awy354","volume":"142","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Liu A, Wang ZJ, Cao Q, Wang W, Lin L, et al. Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer\u2019s disease. Brain. 2019;142:787\u2013807.","journal-title":"Brain"},{"key":"8917_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35749-6","volume":"14","author":"JB Williams","year":"2023","unstructured":"Williams JB, Cao Q, Wang W, Lee YH, Qin L, Zhong P, et al. Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model. Nat Commun. 2023;14:91.","journal-title":"Nat Commun"},{"key":"8917_CR92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41593-018-0291-1","volume":"22","author":"HU Klein","year":"2019","unstructured":"Klein HU, McCabe C, Gjoneska E, Sullivan SE, Kaskow BJ, Tang A, et al. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer\u2019s human brains. Nat Neurosci. 2019;22:37\u201346.","journal-title":"Nat Neurosci"},{"key":"8917_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01865-1","volume":"12","author":"MR Bryan Iii","year":"2024","unstructured":"Bryan Iii MR, Tian X, Tseng JH, Evangelista BA, Ragusa JV, Bryan AF, et al. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2024;12:163.","journal-title":"Acta Neuropathol Commun"},{"key":"8917_CR94","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.celrep.2017.07.082","volume":"20","author":"JH Tseng","year":"2017","unstructured":"Tseng JH, Xie L, Song S, Xie Y, Allen L, Ajit D, et al. The deacetylase HDAC6 mediates endogenous neuritic Tau pathology. Cell Rep. 2017;20:2169\u201383.","journal-title":"Cell Rep"},{"key":"8917_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13081","volume":"19","author":"H Choi","year":"2020","unstructured":"Choi H, Kim HJ, Yang J, Chae S, Lee W, Chung S, et al. Acetylation changes tau interactome to degrade tau in Alzheimer\u2019s disease animal and organoid models. Aging Cell. 2020;19:e13081.","journal-title":"Aging Cell"},{"key":"8917_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22501-9","volume":"12","author":"B Caballero","year":"2021","unstructured":"Caballero B, Bourdenx M, Luengo E, Diaz A, Sohn PD, Chen X, et al. Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice. Nat Commun. 2021;12:2238.","journal-title":"Nat Commun"},{"key":"8917_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19317-4","volume":"11","author":"H Trzeciakiewicz","year":"2020","unstructured":"Trzeciakiewicz H, Ajit D, Tseng JH, Chen Y, Ajit A, Tabassum Z, et al. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat Commun. 2020;11:5522.","journal-title":"Nat Commun"},{"key":"8917_CR98","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.freeradbiomed.2024.09.021","volume":"224","author":"X An","year":"2024","unstructured":"An X, He J, Xie P, Li C, Xia M, Guo D, et al. The effect of tau K677 lactylation on ferritinophagy and ferroptosis in Alzheimer\u2019s disease. Free Radic Biol Med. 2024;224:685\u2013706.","journal-title":"Free Radic Biol Med"},{"key":"8917_CR99","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio R, Lan Y, Donahue G, Sidoli S, Berson A, Srinivasan AR, et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat Genet. 2020;52:1024\u201335.","journal-title":"Nat Genet"},{"key":"8917_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01696-6","volume":"12","author":"DC Xu","year":"2024","unstructured":"Xu DC, Sas-Nowosielska H, Donahue G, Huang H, Pourshafie N, Good CR, et al. Histone acetylation in an Alzheimer\u2019s disease cell model promotes homeostatic amyloid-reducing pathways. Acta Neuropathol Commun. 2024;12:3.","journal-title":"Acta Neuropathol Commun"},{"key":"8917_CR101","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi SJ, Leung SK, Ribarska T, Hannon E, Smith AR, Pishva E, et al. A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat Neurosci. 2018;21:1618\u201327.","journal-title":"Nat Neurosci"},{"key":"8917_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13967","volume":"22","author":"N Li","year":"2023","unstructured":"Li N, Bai N, Zhao X, Cheng R, Wu X, Jiang B, et al. Cooperative effects of SIRT1 and SIRT2 on APP acetylation. Aging Cell. 2023;22:e13967.","journal-title":"Aging Cell"},{"key":"8917_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111062","volume":"40","author":"N Bai","year":"2022","unstructured":"Bai N, Li N, Cheng R, Guan Y, Zhao X, Song Z, et al. Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP\/PS1 transgenic mice. Cell Rep. 2022;40:111062.","journal-title":"Cell Rep"},{"key":"8917_CR104","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.ado1035","volume":"17","author":"R Cheng","year":"2024","unstructured":"Cheng R, Bai N, Liu S, Zhao X, Jiang B, Guo W, et al. The deacetylase SIRT6 reduces amyloid pathology and supports cognition in mice by reducing the stability of APP in neurons. Sci Signal. 2024;17:eado1035.","journal-title":"Sci Signal"},{"key":"8917_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12017-022-08713-2","volume":"25","author":"I Perone","year":"2023","unstructured":"Perone I, Ghena N, Wang J, Mackey C, Wan R, Malla S, et al. Mitochondrial SIRT3 deficiency results in neuronal network hyperexcitability, accelerates age-related A\u03b2 pathology, and renders neurons vulnerable to A\u03b2 toxicity. Neuromol. Med. 2023;25:27\u201339.","journal-title":"Neuromol. Med"},{"key":"8917_CR106","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.immuni.2018.02.016","volume":"48","author":"M Datta","year":"2018","unstructured":"Datta M, Staszewski O, Raschi E, Frosch M, Hagemeyer N, Tay TL, et al. Histone Deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner. Immunity. 2018;48:514\u201329.e516.","journal-title":"Immunity"},{"key":"8917_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1640-z","volume":"16","author":"XY Sun","year":"2019","unstructured":"Sun XY, Zheng T, Yang X, Liu L, Gao SS, Xu HB, et al. HDAC2 hyperexpression alters hippocampal neuronal transcription and microglial activity in neuroinflammation-induced cognitive dysfunction. J Neuroinflamm. 2019;16:249.","journal-title":"J Neuroinflamm"},{"key":"8917_CR108","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, et al. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell. 2017;16:1073\u201382.","journal-title":"Aging Cell"},{"key":"8917_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01156-9","volume":"17","author":"J Cheng","year":"2024","unstructured":"Cheng J, Zhao H. NEK7 induces lactylation in Alzheimer\u2019s disease to promote pyroptosis in BV-2 cells. Mol Brain. 2024;17:81.","journal-title":"Mol Brain"},{"key":"8917_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02879-7","volume":"20","author":"L Wei","year":"2023","unstructured":"Wei L, Yang X, Wang J, Wang Z, Wang Q, Ding Y, et al. H3K18 lactylation of senescent microglia potentiates brain aging and Alzheimer\u2019s disease through the NF\u03baB signaling pathway. J Neuroinflamm. 2023;20:208.","journal-title":"J Neuroinflamm"},{"key":"8917_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12979-023-00390-4","volume":"20","author":"H Han","year":"2023","unstructured":"Han H, Zhao Y, Du J, Wang S, Yang X, Li W, et al. Exercise improves cognitive dysfunction and neuroinflammation in mice through Histone H3 lactylation in microglia. Immun Ageing. 2023;20:63.","journal-title":"Immun Ageing"},{"key":"8917_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-015-9098-1","volume":"12","author":"KW Anderson","year":"2015","unstructured":"Anderson KW, Turko IV. Histone post-translational modifications in frontal cortex from human donors with Alzheimer\u2019s disease. Clin Proteom. 2015;12:26.","journal-title":"Clin Proteom"},{"key":"8917_CR113","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.fob.2015.06.009","volume":"5","author":"KW Anderson","year":"2015","unstructured":"Anderson KW, Mast N, Pikuleva IA, Turko IV. Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice. FEBS Open Bio. 2015;5:550\u20136.","journal-title":"FEBS Open Bio"},{"key":"8917_CR114","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11357-008-9050-7","volume":"30","author":"NH Myung","year":"2008","unstructured":"Myung NH, Zhu X, Kruman II, Castellani RJ, Petersen RB, Siedlak SL, et al. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age. 2008;30:209\u201315.","journal-title":"Age"},{"key":"8917_CR115","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51:745\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8917_CR116","doi-asserted-by":"crossref","unstructured":"Church FC. Treatment options for motor and non-motor symptoms of Parkinson\u2019s Disease. Biomolecules 2021;11:612.","DOI":"10.3390\/biom11040612"},{"key":"8917_CR117","doi-asserted-by":"crossref","unstructured":"Cacabelos R. Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. 2017;18:551.","DOI":"10.3390\/ijms18030551"},{"key":"8917_CR118","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12640-021-00392-4","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Jiang Y, Yang Y, Huang X, Sun C. SIRT1 protects dopaminergic neurons in Parkinson\u2019s disease models via PGC-1\u03b1-mediated mitochondrial biogenesis. Neurotox Res. 2021;39:1393\u2013404.","journal-title":"Neurotox Res"},{"key":"8917_CR119","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/hmg\/ddx100","volume":"26","author":"H Shi","year":"2017","unstructured":"Shi H, Deng HX, Gius D, Schumacker PT, Surmeier DJ, Ma YC. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress. Hum Mol Genet. 2017;26:1915\u201326.","journal-title":"Hum Mol Genet"},{"key":"8917_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol Neurodegener. 2021;16:31.","journal-title":"Mol Neurodegener"},{"key":"8917_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1422362","volume":"18","author":"M Huang","year":"2024","unstructured":"Huang M, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Mitochondrial stress-induced H4K12 hyperacetylation dysregulates transcription in Parkinson\u2019s disease. Front Cell Neurosci. 2024;18:1422362.","journal-title":"Front Cell Neurosci"},{"key":"8917_CR122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT. Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett. 2018;666:48\u201357.","journal-title":"Neurosci Lett"},{"key":"8917_CR123","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1017\/S1461145708009024","volume":"11","author":"X Wu","year":"2008","unstructured":"Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol. 2008;11:1123\u201334.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8917_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1052925","volume":"14","author":"M Huang","year":"2023","unstructured":"Huang M, Malovic E, Ealy A, Jin H, Anantharam V, Kanthasamy A, et al. Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation. Front Immunol. 2023;14:1052925.","journal-title":"Front Immunol"},{"key":"8917_CR125","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00018-024-05176-5","volume":"81","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang R, Zhou H, Wu D, Cao Y, Zhang C, et al. Inhibition of EHMT1\/2 rescues synaptic damage and motor impairment in a PD mouse model. Cell Mol Life Sci. 2024;81:128.","journal-title":"Cell Mol Life Sci"},{"key":"8917_CR126","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science. 2007;317:516\u20139.","journal-title":"Science"},{"key":"8917_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652882","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Liu T, Wu TT, Feng Y, Peng SJ, Yin H, et al. SIRT1 deacetylates TET2 and promotes its ubiquitination degradation to achieve neuroprotection against Parkinson\u2019s disease. Front Neurol. 2021;12:652882.","journal-title":"Front Neurol"},{"key":"8917_CR128","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","volume":"147","author":"Y Chu","year":"2024","unstructured":"Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Nigrostriatal tau pathology in Parkinsonism and Parkinson\u2019s disease. Brain. 2024;147:444\u201357.","journal-title":"Brain"},{"key":"8917_CR129","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","volume":"225","author":"J Wills","year":"2010","unstructured":"Wills J, Jones J, Haggerty T, Duka V, Joyce JN, Sidhu A. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp Neurol. 2010;225:210\u20138.","journal-title":"Exp Neurol"},{"key":"8917_CR130","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","volume":"23","author":"B Roy","year":"2014","unstructured":"Roy B, Jackson GR. Interactions between Tau and \u03b1-synuclein augment neurotoxicity in a Drosophila model of Parkinson\u2019s disease. Hum Mol Genet. 2014;23:3008\u201323.","journal-title":"Hum Mol Genet"},{"key":"8917_CR131","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/brain\/awac171","volume":"145","author":"L Pan","year":"2022","unstructured":"Pan L, Li C, Meng L, Tian Y, He M, Yuan X, et al. Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease. Brain. 2022;145:3454\u201371.","journal-title":"Brain"},{"key":"8917_CR132","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbadis.2018.11.014","volume":"1865","author":"AR Esteves","year":"2019","unstructured":"Esteves AR, Palma AM, Gomes R, Santos D, Silva DF, Cardoso SM. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer\u2019s and Parkinson disease pathology. Biochim et Biophys Acta Mol Basis Dis. 2019;1865:2008\u201323.","journal-title":"Biochim et Biophys Acta Mol Basis Dis"},{"key":"8917_CR133","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13105-023-00978-w","volume":"79","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhou T, Su Y, He L, Wang Z. Involvement of histone methylation in the regulation of neuronal death. J Physiol Biochem. 2023;79:685\u201393.","journal-title":"J Physiol Biochem"},{"key":"8917_CR134","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41419-020-03105-5","volume":"11","author":"MD Mu","year":"2020","unstructured":"Mu MD, Qian ZM, Yang SX, Rong KL, Yung WH, Ke Y. Therapeutic effect of a histone demethylase inhibitor in Parkinson\u2019s disease. Cell Death Dis. 2020;11:927.","journal-title":"Cell Death Dis"},{"key":"8917_CR135","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0271678X231165653","volume":"43","author":"T Lan","year":"2023","unstructured":"Lan T, Hu L, Sun T, Wang X, Xiao Z, Shen D, et al. H3K9 trimethylation dictates neuronal ferroptosis through repressing Tfr1. J Cereb Blood Flow Metab. 2023;43:1365\u201381.","journal-title":"J Cereb Blood Flow Metab"},{"key":"8917_CR136","doi-asserted-by":"crossref","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N, MacFarlane H. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"8917_CR137","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, et al. ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci USA. 2006;103:19176\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR138","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-017-1732-8","volume":"134","author":"J Lee","year":"2017","unstructured":"Lee J, Hwang YJ, Kim Y, Lee MY, Hyeon SJ, Lee S, et al. Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington\u2019s disease. Acta Neuropathol. 2017;134:729\u201348.","journal-title":"Acta Neuropathol"},{"key":"8917_CR139","doi-asserted-by":"publisher","first-page":"e0144398","DOI":"10.1371\/journal.pone.0144398","volume":"10","author":"X Dong","year":"2015","unstructured":"Dong X, Tsuji J, Labadorf A, Roussos P, Chen JF, Myers RH, et al. The role of H3K4me3 in transcriptional regulation is altered in Huntington\u2019s disease. PloS ONE. 2015;10:e0144398.","journal-title":"PloS ONE"},{"key":"8917_CR140","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr.","year":"2001","unstructured":"Nucifora FC Jr., Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291:2423\u20138.","journal-title":"Science"},{"key":"8917_CR141","doi-asserted-by":"crossref","unstructured":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci. 2017;20:648\u201360.","DOI":"10.1038\/nn.4532"},{"key":"8917_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105092","volume":"146","author":"P Narayan","year":"2020","unstructured":"Narayan P, Reid S, Scotter EL, McGregor AL, Mehrabi NF, Singh-Bains MK, et al. Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains. Neurobiol Dis. 2020;146:105092.","journal-title":"Neurobiol Dis"},{"key":"8917_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105074","volume":"148","author":"JW Hyeon","year":"2021","unstructured":"Hyeon JW, Kim AH, Yano H. Epigenetic regulation in Huntington\u2019s disease. Neurochem Int. 2021;148:105074.","journal-title":"Neurochem Int"},{"key":"8917_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18255-5","volume":"11","author":"AT Lu","year":"2020","unstructured":"Lu AT, Narayan P, Grant MJ, Langfelder P, Wang N, Kwak S, et al. DNA methylation study of Huntington\u2019s disease and motor progression in patients and in animal models. Nat Commun. 2020;11:4529.","journal-title":"Nat Commun"},{"key":"8917_CR145","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nm.3617","volume":"20","author":"M Fern\u00e1ndez-Nogales","year":"2014","unstructured":"Fern\u00e1ndez-Nogales M, Cabrera JR, Santos-Galindo M, Hoozemans JJ, Ferrer I, Rozemuller AJ, et al. Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods. Nat Med. 2014;20:881\u20135.","journal-title":"Nat Med"},{"key":"8917_CR146","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/hmg\/ddu421","volume":"24","author":"D Blum","year":"2015","unstructured":"Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, et al. Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet. 2015;24:76\u201385.","journal-title":"Hum Mol Genet"},{"key":"8917_CR147","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/hmg\/ddu456","volume":"24","author":"M Gratuze","year":"2015","unstructured":"Gratuze M, No\u00ebl A, Julien C, Cisbani G, Milot-Rousseau P, Morin F, et al. Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease. Hum Mol Genet. 2015;24:86\u201399.","journal-title":"Hum Mol Genet"},{"key":"8917_CR148","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363\u201380.","journal-title":"Lancet"},{"key":"8917_CR149","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1474-4422(21)00341-0","volume":"21","author":"BF Boeve","year":"2022","unstructured":"Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21:258\u201372.","journal-title":"Lancet Neurol"},{"key":"8917_CR150","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s12031-011-9636-x","volume":"45","author":"C Lomen-Hoerth","year":"2011","unstructured":"Lomen-Hoerth C. Clinical phenomenology and neuroimaging correlates in ALS-FTD. J Mol Neurosci. 2011;45:656\u201362.","journal-title":"J Mol Neurosci"},{"key":"8917_CR151","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","volume":"9","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995\u20131007.","journal-title":"Lancet Neurol"},{"key":"8917_CR152","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12031-011-9637-9","volume":"45","author":"F Fecto","year":"2011","unstructured":"Fecto F, Siddique T. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia. J Mol Neurosci. 2011;45:663\u201375.","journal-title":"J Mol Neurosci"},{"key":"8917_CR153","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnins.2020.00042","volume":"14","author":"YA Abramzon","year":"2020","unstructured":"Abramzon YA, Fratta P, Traynor BJ, Chia R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2020;14:42.","journal-title":"Front Neurosci"},{"key":"8917_CR154","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","volume":"26","author":"T Niccoli","year":"2017","unstructured":"Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS\/FTD. Hum Mol Genet. 2017;26:R105\u2013r113.","journal-title":"Hum Mol Genet"},{"key":"8917_CR155","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s40265-022-01769-1","volume":"82","author":"SA Johnson","year":"2022","unstructured":"Johnson SA, Fang T, De Marchi F, Neel D, Van Weehaeghe D, Berry JD, et al. Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents. Drugs. 2022;82:1367\u201388.","journal-title":"Drugs"},{"key":"8917_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1456052","volume":"17","author":"RMA Fisher","year":"2024","unstructured":"Fisher RMA, Torrente MP. Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics. Front Mol Neurosci. 2024;17:1456052.","journal-title":"Front Mol Neurosci"},{"key":"8917_CR157","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245\u201356.","journal-title":"Neuron"},{"key":"8917_CR158","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","volume":"126","author":"VV Belzil","year":"2013","unstructured":"Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, et al. Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895\u2013905.","journal-title":"Acta Neuropathol"},{"key":"8917_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0185-9","volume":"12","author":"R Esanov","year":"2017","unstructured":"Esanov R, Cabrera GT, Andrade NS, Gendron TF, Brown RH Jr, Benatar M, et al. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS\/FTD. Mol Neurodegener. 2017;12:46.","journal-title":"Mol Neurodegener"},{"key":"8917_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-0816-9","volume":"12","author":"N Jury","year":"2020","unstructured":"Jury N, Abarzua S, Diaz I, Guerra MV, Ampuero E, Cubillos P, et al. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice. Clin Epigenetics. 2020;12:32.","journal-title":"Clin Epigenetics"},{"key":"8917_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41033-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Jaiswal MK, Chien JF, Kozlenkov A, Jung J, Zhou P, et al. Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation. Nat Commun. 2023;14:5714.","journal-title":"Nat Commun"},{"key":"8917_CR162","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neuron.2023.01.022","volume":"111","author":"Y Liu","year":"2023","unstructured":"Liu Y, Huang Z, Liu H, Ji Z, Arora A, Cai D, et al. DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat. Neuron. 2023;111:1205\u20131221.e1209.","journal-title":"Neuron"},{"key":"8917_CR163","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acschemneuro.7b00297","volume":"9","author":"K Chen","year":"2018","unstructured":"Chen K, Bennett SA, Rana N, Yousuf H, Said M, Taaseen S, et al. Neurodegenerative disease proteinopathies are connected to distinct histone post-translational modification landscapes. ACS Chem Neurosci. 2018;9:838\u201348.","journal-title":"ACS Chem Neurosci"},{"key":"8917_CR164","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910622","volume":"12","author":"CC Wu","year":"2020","unstructured":"Wu CC, Jin LW, Wang IF, Wei WY, Ho PC, Liu YC, et al. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies. EMBO Mol Med. 2020;12:e10622.","journal-title":"EMBO Mol Med"},{"key":"8917_CR165","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1091\/mbc.e14-05-1007","volume":"25","author":"JC Schwartz","year":"2014","unstructured":"Schwartz JC, Podell ER, Han SS, Berry JD, Eggan KC, Cech TR. FUS is sequestered in nuclear aggregates in ALS patient fibroblasts. Mol Biol Cell. 2014;25:2571\u20138.","journal-title":"Mol Biol Cell"},{"key":"8917_CR166","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/hmg\/ddu494","volume":"24","author":"M Tibshirani","year":"2015","unstructured":"Tibshirani M, Tradewell ML, Mattina KR, Minotti S, Yang W, Zhou H, et al. Cytoplasmic sequestration of FUS\/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum Mol Genet. 2015;24:773\u201386.","journal-title":"Hum Mol Genet"},{"key":"8917_CR167","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0750-2","volume":"7","author":"E Rossaert","year":"2019","unstructured":"Rossaert E, Pollari E, Jaspers T, Van Helleputte L, Jarpe M, Van Damme P, et al. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun. 2019;7:107.","journal-title":"Acta Neuropathol Commun"},{"key":"8917_CR168","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1093\/hmg\/ddaa159","volume":"29","author":"A Arenas","year":"2020","unstructured":"Arenas A, Chen J, Kuang L, Barnett KR, Kasarskis EJ, Gal J, et al. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS. Hum Mol Genet. 2020;29:2684\u201397.","journal-title":"Hum Mol Genet"},{"key":"8917_CR169","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391:1622\u201336.","journal-title":"Lancet"},{"key":"8917_CR170","first-page":"527","volume":"140","author":"J Correale","year":"2017","unstructured":"Correale J, Gait\u00e1n MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140:527\u201346.","journal-title":"Brain"},{"key":"8917_CR171","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nrneurol.2012.198","volume":"8","author":"A Ascherio","year":"2012","unstructured":"Ascherio A, Munger KL, L\u00fcnemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol. 2012;8:602\u201312.","journal-title":"Nat Rev Neurol"},{"key":"8917_CR172","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-018-0163-5","volume":"12","author":"H He","year":"2018","unstructured":"He H, Hu Z, Xiao H, Zhou F, Yang B. The tale of histone modifications and its role in multiple sclerosis. Hum Genom. 2018;12:31.","journal-title":"Hum Genom"},{"key":"8917_CR173","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni969","volume":"4","author":"RA Seder","year":"2003","unstructured":"Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol. 2003;4:835\u201342.","journal-title":"Nat Immunol"},{"key":"8917_CR174","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","volume":"585","author":"C Larochelle","year":"2011","unstructured":"Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011;585:3770\u201380.","journal-title":"FEBS Lett"},{"key":"8917_CR175","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2014.00603","volume":"5","author":"E Muraille","year":"2014","unstructured":"Muraille E, Leo O, Moser M. TH1\/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front Immunol. 2014;5:603.","journal-title":"Front Immunol"},{"key":"8917_CR176","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/icb.2008.106","volume":"87","author":"L Wang","year":"2009","unstructured":"Wang L, Tao R, Hancock WW. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol. 2009;87:195\u2013202.","journal-title":"Immunol Cell Biol"},{"key":"8917_CR177","doi-asserted-by":"publisher","first-page":"e201800039","DOI":"10.26508\/lsa.201800039","volume":"1","author":"L Sun","year":"2018","unstructured":"Sun L, Telles E, Karl M, Cheng F, Luetteke N, Sotomayor EM, et al. Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model. Life Sci Alliance. 2018;1:e201800039.","journal-title":"Life Sci Alliance"},{"key":"8917_CR178","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuroscience.2012.07.013","volume":"221","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang ZY, Wu Y, Schluesener HJ. Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats. Neuroscience. 2012;221:140\u201350.","journal-title":"Neuroscience"},{"key":"8917_CR179","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.expneurol.2012.12.006","volume":"241","author":"Z Ge","year":"2013","unstructured":"Ge Z, Da Y, Xue Z, Zhang K, Zhuang H, Peng M, et al. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Exp Neurol. 2013;241:56\u201366.","journal-title":"Exp Neurol"},{"key":"8917_CR180","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jmcb\/mjv022","volume":"7","author":"Z Liu","year":"2015","unstructured":"Liu Z, Cao W, Xu L, Chen X, Zhan Y, Yang Q, et al. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. J Mol Cell Biol. 2015;7:505\u201316.","journal-title":"J Mol Cell Biol"},{"key":"8917_CR181","doi-asserted-by":"publisher","first-page":"10333","DOI":"10.1523\/JNEUROSCI.22-23-10333.2002","volume":"22","author":"M Marin-Husstege","year":"2002","unstructured":"Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci. 2002;22:10333\u201345.","journal-title":"J Neurosci"},{"key":"8917_CR182","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nn.2172","volume":"11","author":"S Shen","year":"2008","unstructured":"Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci. 2008;11:1024\u201334.","journal-title":"Nat Neurosci"},{"key":"8917_CR183","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1523\/JNEUROSCI.4507-10.2011","volume":"31","author":"X Pedre","year":"2011","unstructured":"Pedre X, Mastronardi F, Bruck W, L\u00f3pez-Rodas G, Kuhlmann T, Casaccia P. Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions. J Neurosci. 2011;31:3435\u201345.","journal-title":"J Neurosci"},{"key":"8917_CR184","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41593-018-0101-9","volume":"21","author":"R Nativio","year":"2018","unstructured":"Nativio R, Donahue G, Berson A, Lan Y, Amlie-Wolf A, Tuzer F, et al. Dysregulation of the epigenetic landscape of normal aging in Alzheimer\u2019s disease. Nat Neurosci. 2018;21:497\u2013505.","journal-title":"Nat Neurosci"},{"key":"8917_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.61","volume":"1","author":"B Tang","year":"2011","unstructured":"Tang B, Dean B, Thomas EA. Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry. 2011;1:e64.","journal-title":"Transl Psychiatry"},{"key":"8917_CR186","doi-asserted-by":"crossref","unstructured":"Persico G, Casciaro F, Amatori S, Rusin M, Cantatore F, Perna A, et al. Histone H3 Lysine 4 and 27 trimethylation landscape of human Alzheimer\u2019s Disease. Cells. 2022;11:734.","DOI":"10.3390\/cells11040734"},{"key":"8917_CR187","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JAD-150493","volume":"51","author":"JA Luchsinger","year":"2016","unstructured":"Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, et al. Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial. J Alzheimer\u2019s Dis. 2016;51:501\u201314.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"8917_CR188","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-190120","volume":"74","author":"W Fernando","year":"2020","unstructured":"Fernando W, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WLF, et al. Sodium butyrate reduces brain Amyloid-\u03b2 levels and improves cognitive memory performance in an Alzheimer\u2019s disease transgenic mouse model at an early disease stage. J Alzheimer\u2019s Dis. 2020;74:91\u20139.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"8917_CR189","first-page":"876","volume":"44","author":"F Wang","year":"2024","unstructured":"Wang F, Zhang Z, Sun Y, Yang L, Guo T, Pan Y, et al. Bmal1 mediates the neuroprotective effect of sodium butyrate in a mouse model of Parkinson\u2019s disease. J South Med Univ. 2024;44:876\u201384.","journal-title":"J South Med Univ"},{"key":"8917_CR190","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","volume":"51","author":"AG Xuan","year":"2015","unstructured":"Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH, et al. Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2015;51:300\u201312.","journal-title":"Mol Neurobiol"},{"key":"8917_CR191","volume":"2015","author":"JC Ximenes","year":"2015","unstructured":"Ximenes JC, Neves KR, Leal LK, do Carmo MR, Brito GA, Naffah-Mazzacoratti Mda G, et al. Valproic acid neuroprotection in the 6-OHDA model of parkinson\u2019s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties. J Neurodegener Dis. 2015;2015:313702.","journal-title":"J Neurodegener Dis"},{"key":"8917_CR192","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, et al. Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice. Alzheimer\u2019s Res Ther. 2021;13:7.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"8917_CR193","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuropharm.2015.07.015","volume":"99","author":"H Suo","year":"2015","unstructured":"Suo H, Wang P, Tong J, Cai L, Liu J, Huang D, et al. NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology. 2015;99:67\u201378.","journal-title":"Neuropharmacology"},{"key":"8917_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110429","volume":"375","author":"KM Athaide Rocha","year":"2023","unstructured":"Athaide Rocha KM, Machado FR, Poetini M, Giacomeli R, Boeira SP, Jesse CR, et al. Assessment of suberoylanilide hydroxamic acid on a Alzheimer\u2019s disease model induced by \u03b2-amyloid((1-42)) in aged female mice: neuromodulatory and epigenetic effect. Chem-Biol Interact. 2023;375:110429.","journal-title":"Chem-Biol Interact"},{"key":"8917_CR195","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","volume":"165","author":"SH Chen","year":"2012","unstructured":"Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol. 2012;165:494\u2013505.","journal-title":"Br J Pharmacol"},{"key":"8917_CR196","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease. Proc Natl Acad Sci USA. 2003;100:2041\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8917_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"C Moussa","year":"2017","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflamm. 2017;14:1.","journal-title":"J Neuroinflamm"},{"key":"8917_CR198","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.18632\/aging.102558","volume":"11","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2019","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Marsal-Garc\u00eda L, Bellver-Sanchis A, Kondengaden SM, Turga RC, V\u00e1zquez S, et al. Pharmacological inhibition of G9a\/GLP restores cognition and reduces oxidative stress, neuroinflammation and \u03b2-Amyloid plaques in an early-onset Alzheimer\u2019s disease mouse model. Aging. 2019;11:11591\u2013608.","journal-title":"Aging"},{"key":"8917_CR199","doi-asserted-by":"publisher","first-page":"970","DOI":"10.14336\/AD.2021.1213","volume":"13","author":"FF Cheng","year":"2022","unstructured":"Cheng FF, Liu YL, Du J, Lin JT. Metformin\u2019s mechanisms in attenuating hallmarks of aging and age-related disease. Aging Dis. 2022;13:970\u201386.","journal-title":"Aging Dis"},{"key":"8917_CR200","doi-asserted-by":"crossref","unstructured":"Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G. Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol. 2016;19:pyw047.","DOI":"10.1093\/ijnp\/pyw047"},{"key":"8917_CR201","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2315106","volume":"2020","author":"XY Lu","year":"2020","unstructured":"Lu XY, Huang S, Chen QB, Zhang D, Li W, Ao R, et al. Metformin ameliorates A\u03b2 pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2020;2020:2315106.","journal-title":"Oxid Med Cell Longev"},{"key":"8917_CR202","doi-asserted-by":"crossref","unstructured":"Thellung S, Corsaro A, Nizzari M, Barbieri F, Florio T. Autophagy activator drugs: a new opportunity in neuroprotection from misfolded protein toxicity. Int J Mol Sci. 2019;20:901.","DOI":"10.3390\/ijms20040901"},{"key":"8917_CR203","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s12035-023-03626-y","volume":"61","author":"A Paniri","year":"2024","unstructured":"Paniri A, Hosseini MM, Akhavan-Niaki H. Alzheimer\u2019s disease-related epigenetic changes: novel therapeutic targets. Mol Neurobiol. 2024;61:1282\u2013317.","journal-title":"Mol Neurobiol"},{"key":"8917_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117278","volume":"243","author":"R Gupta","year":"2020","unstructured":"Gupta R, Ambasta RK, Kumar P. Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders. Life Sci. 2020;243:117278.","journal-title":"Life Sci"},{"key":"8917_CR205","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schi\u00f6th HB. Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol. 2021;87:4577\u201397.","journal-title":"Br J Clin Pharmacol"},{"key":"8917_CR206","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nm.2396","volume":"17","author":"C d\u2019Ydewalle","year":"2011","unstructured":"d\u2019Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med. 2011;17:968\u201374.","journal-title":"Nat Med"},{"key":"8917_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105274","volume":"163","author":"S Pulya","year":"2021","unstructured":"Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B. HDAC6 as privileged target in drug discovery: a perspective. Pharmacol Res. 2021;163:105274.","journal-title":"Pharmacol Res"},{"key":"8917_CR208","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s12035-014-8820-8","volume":"51","author":"LM Collins","year":"2015","unstructured":"Collins LM, Adriaanse LJ, Theratile SD, Hegarty SV, Sullivan AM, O\u2019Keeffe GW. Class-IIa histone deacetylase inhibition promotes the growth of neural processes and protects them against neurotoxic insult. Mol Neurobiol. 2015;51:1432\u201342.","journal-title":"Mol Neurobiol"},{"key":"8917_CR209","first-page":"2831","volume":"16","author":"J Fu","year":"2024","unstructured":"Fu J, An L. Histone methylation, energy metabolism, and Alzheimer\u2019s disease. Aging Dis. 2024;16:2831\u201358.","journal-title":"Aging Dis"},{"key":"8917_CR210","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.mehy.2015.07.011","volume":"85","author":"RS Monteiro-Junior","year":"2015","unstructured":"Monteiro-Junior RS, Cevada T, Oliveira BR, Lattari E, Portugal EM, Carvalho A, et al. We need to move more: neurobiological hypotheses of physical exercise as a treatment for Parkinson\u2019s disease. Med hypotheses. 2015;85:537\u201341.","journal-title":"Med hypotheses"},{"key":"8917_CR211","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.freeradbiomed.2024.04.237","volume":"220","author":"F Gomez-Pinilla","year":"2024","unstructured":"Gomez-Pinilla F, Thapak P. Exercise epigenetics is fueled by cell bioenergetics: supporting role on brain plasticity and cognition. Free Radic Biol Med. 2024;220:43\u201355.","journal-title":"Free Radic Biol Med"},{"key":"8917_CR212","first-page":"1097","volume":"70","author":"E Ravussin","year":"2015","unstructured":"Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, et al. A 2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol Ser A Biomed Sci Med Sci. 2015;70:1097\u2013104.","journal-title":"J Gerontol Ser A Biomed Sci Med Sci"},{"key":"8917_CR213","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/alz.12206","volume":"17","author":"M Fortier","year":"2021","unstructured":"Fortier M, Castellano CA, St-Pierre V, Myette-C\u00f4t\u00e9 \u00c9, Langlois F, Roy M, et al. A ketogenic drink improves cognition in mild cognitive impairment: results of a 6-month RCT. Alzheimer\u2019s Dement. 2021;17:543\u201352.","journal-title":"Alzheimer\u2019s Dement"},{"key":"8917_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981285","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y, et al. Function and mechanism of histone \u03b2-hydroxybutyrylation in health and disease. Front Immunol. 2022;13:981285.","journal-title":"Front Immunol"},{"key":"8917_CR215","doi-asserted-by":"crossref","unstructured":"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, et al. Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases. Int J Mol Sci. 2023;25:124.","DOI":"10.3390\/ijms25010124"},{"key":"8917_CR216","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cell.2022.12.017","volume":"186","author":"X Liu","year":"2023","unstructured":"Liu X, Liu Z, Wu Z, Ren J, Fan Y, Sun L, et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell. 2023;186:287\u2013304.e226.","journal-title":"Cell"},{"key":"8917_CR217","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13287-022-02959-0","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Gong M, Jian T, Li J, Yang C, Ma Q, et al. Engrafted glial progenitor cells yield long-term integration and sensory improvement in aged mice. Stem Cell Res Ther. 2022;13:285.","journal-title":"Stem Cell Res Ther"},{"key":"8917_CR218","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2025.102743","volume":"247","author":"A Ant\u00f3n-Fern\u00e1ndez","year":"2025","unstructured":"Ant\u00f3n-Fern\u00e1ndez A, Ruiz de Alegr\u00eda \u00c1, Mariscal-Casero A, Rold\u00e1n-L\u00e1zaro M, Peinado-Cauchola R, \u00c1vila J, et al. Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\u2019s disease. Prog Neurobiol. 2025;247:102743.","journal-title":"Prog Neurobiol"},{"key":"8917_CR219","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo A, Reddy P, Martinez-Redondo P, Platero-Luengo A, Hatanaka F, Hishida T, et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell. 2016;167:1719\u201333.e1712.","journal-title":"Cell"},{"key":"8917_CR220","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molcel.2023.10.006","volume":"84","author":"Z Wu","year":"2024","unstructured":"Wu Z, Qu J, Zhang W, Liu GH. Stress, epigenetics, and aging: unraveling the intricate crosstalk. Mol Cell. 2024;84:34\u201354.","journal-title":"Mol Cell"},{"key":"8917_CR221","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-020-2580-3","volume":"11","author":"S Sanna","year":"2020","unstructured":"Sanna S, Esposito S, Masala A, Sini P, Nieddu G, Galioto M, et al. HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo. Cell Death Dis. 2020;11:369.","journal-title":"Cell Death Dis"},{"key":"8917_CR222","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1020556","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao Y, Li X, Zhai L, Zheng H, Yan Y, et al. Biological and therapeutic role of LSD1 in Alzheimer\u2019s diseases. Front Pharmacol. 2022;13:1020556.","journal-title":"Front Pharmacol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08917-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:06:54Z","timestamp":1785521214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08917-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":222,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8917"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08917-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This article does not report any studies involving human participants or animals, nor does it disclose any patient data. Therefore, no additional ethical approval is required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"YZ and BH have approved the final version of this manuscript and agree with its submission to\n                      Cell Death & Disease.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"664"}}